Prosecution Insights
Prosecution Insights
Technology area: Medical Devices & Mechanical Engineering
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Vergent Bioscience Inc. is currently engaged in patent prosecution within the Medical Devices & Mechanical Engineering technology area. The company's portfolio includes 1 pending office action, which is being processed in 1 distinct art unit. This reflects a focused approach to intellectual property, with current efforts concentrated on a specific technical domain.
The prosecution is being handled by 1 distinct examiner, BOLER, RYNAE E. As the busiest examiner for the portfolio, BOLER, RYNAE E is responsible for 1 busiest examiner pending office action. This means that the company's immediate patent outcomes are entirely dependent on the review and feedback of this single individual within the 1 distinct art unit.
For a practitioner, the presence of 1 distinct examiner and 1 pending office action simplifies the management of the portfolio but also centralizes the risk. There are no other active examiners or art units to provide a broader context for the company's Medical Devices & Mechanical Engineering claims. Therefore, the strategy must be highly tailored to the specific requirements of BOLER, RYNAE E to ensure a successful prosecution.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BOLER, RYNAE E | 1 | 62.4% | +8.8% |
| Art Unit | Apps |
|---|---|
| 3795 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18793215 | Methods for Localization of Cancerous Tissue Using Fluorescent Molecular Imaging Agent for Diagnosis or Treatment | BOLER, RYNAE E | 3795 | §103 | Non-Final OA | — | Pending | Aug 02, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial